ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633271; 2) Community: the network communities that were significantly associated with the response to NSC 633271; 3) Molecule: the relationships between components within communities and NSC 633271; 4) MDR: the compounds that were significantly associated with the NSC 633271.

NSC Compound Enrichment Correlation
NSC 691424 Null 0.00248668807445195 -0.023580645
NSC 102067 6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 0.00334162892839391 0.19798362
NSC 624873 Null 0.00334162892839391 0.14958714
NSC 672304 Null 0.00334162892839397 0.31208551
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00334162892839397 0.38112644
NSC 726217 Combretastatin A4-analogue 0.00334162892839397 0.1993832
NSC 743532 Null 0.00334162892839397 0.08458053
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.00334162892839397 0.29541584
NSC 762346 Null 0.00334162892839397 0.11238999
NSC 154572 Null 0.00336064452966828 0.11753139
Total:75  Current:8    [First] [Prev] [Next] [Last]